Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors-Reference-Cited by-同舟云学术

Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors

Published:2007-12-23 Issue:1 Volume:14 Page:93-97
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Bauer Thomas R,Allen James M,Hai Mehreen,Tuschong Laura M,Khan Iram F,Olson Erik M,Adler Rima L,Burkholder Tanya H,Gu Yu-chen,Russell David W,Hickstein Dennis D

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1695.pdf

Reference30 articles.

1. Aiuti, A. et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410–2413 (2002).

2. Gaspar, H.B. et al. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol. Ther. 14, 505–513 (2006).

3. Hacein-Bey-Abina, S. et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185–1193 (2002).

4. Ott, M.G. et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401–409 (2006).

5. Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415–419 (2003).

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1;Human Gene Therapy;2022-12-01

2. Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I;Molecular Therapy - Methods & Clinical Development;2022-09

3. Retroviral Vectors for Gene Therapy of Monogenic Diseases;Biotechnologies for Gene Therapy;2022

4. Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges;Frontiers in Molecular Biosciences;2021-05-12

5. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration;Molecular Therapy;2021-04